Evidence that opioids may have toll-like receptor 4 and MD-2 effectsMark R. Hutchinson, Linda R. Watkins, Stefanie Chan et al.|Brain Behavior and Immunity|2009Cited by 574
Morphine paradoxically prolongs neuropathic pain in rats by amplifying spinal NLRP3 inflammasome activationPeter M. Grace, Linda R. Watkins, Keith A. Strand et al.|Proceedings of the National Academy of Sciences|2016Cited by 378
Opioid Activation of Toll-Like Receptor 4 Contributes to Drug ReinforcementMark R. Hutchinson, Linda R. Watkins, Alexis L. Northcutt et al.|Journal of Neuroscience|2012Cited by 349
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signalingAlexis L. Northcutt, Linda R. Watkins, Mark R. Hutchinson et al.|Molecular Psychiatry|2015Cited by 221
Pharmacological characterization of the opioid inactive isomers (+)‐naltrexone and (+)‐naloxone as antagonists of toll‐like receptor 4Xiaohui Wang, Linda R. Watkins, Yu Zhang et al.|British Journal of Pharmacology|2015Cited by 173